U.S. Biological Safety Testing Products And Services Market Size & Outlook

The biological safety testing products and services market in the United States is expected to reach a projected revenue of US$ 2,637.8 million by 2030. A compound annual growth rate of 9.9% is expected of the United States biological safety testing products and services market from 2024 to 2030.
Revenue, 2023 (US$M)
$1,359.1
Forecast, 2030 (US$M)
$2,637.8
CAGR, 2024 - 2030
9.9%
Report Coverage
U.S.

U.S. biological safety testing products and services market, 2018-2030 (US$M)

U.S.

Related Markets

U.S. biological safety testing products and services market highlights

  • The U.S. biological safety testing products and services market generated a revenue of USD 1,359.1 million in 2023 and is expected to reach USD 2,637.8 million by 2030.
  • The U.S. market is expected to grow at a CAGR of 9.9% from 2024 to 2030.
  • In terms of segment, reagents & kits was the largest revenue generating product in 2023.
  • Services is the most lucrative product segment registering the fastest growth during the forecast period.


Biological safety testing products and services market data book summary

Market revenue in 2023USD 1,359.1 million
Market revenue in 2030USD 2,637.8 million
Growth rate9.9% (CAGR from 2023 to 2030)
Largest segmentReagents & kits
Fastest growing segmentServices
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationReagents & kits, Services, Instruments
Key market players worldwideCharles River Laboratories International Inc, BSL-BIOSERVICE Scientific Laboratories GmbH, Merck KGaA, Samsung BioLogics, Sartorius AG, Eurofins Scientific SE, SGS AG, Thermo Fisher Scientific Inc, BioMerieux SA, Lonza Group Ltd


Other key industry trends

  • In terms of revenue, U.S. accounted for 29.7% of the global biological safety testing products and services market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In North America, U.S. biological safety testing products and services market is projected to lead the regional market in terms of revenue in 2030.
  • Canada is the fastest growing regional market in North America and is projected to reach USD 545.1 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biological Safety Testing Products And Services Market Scope

Biological safety testing products and services market segmentation & scope
Reagents & kits
Services
Instruments
Stem cell
Tissue & tissue based products
Gene therapy
Blood & blood-based products
Vaccines
Monoclonal antibodies
Recombinant protein
Sterility tests
Cell line authentication and characterization tests
Bioburden tests
Endotoxin tests
Adventitious agent detection tests
Residual host contamination detection tests
Others

Biological Safety Testing Products And Services Market Companies

Name Profile # Employees HQ Website

U.S. biological safety testing products and services market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biological safety testing products and services market will help companies and investors design strategic landscapes.


Reagents & kits was the largest segment with a revenue share of 39.86% in 2023. Horizon Databook has segmented the U.S. biological safety testing products and services market based on reagents & kits, services, instruments covering the revenue growth of each sub-segment from 2018 to 2030.


The U.S. accounted for the largest share of over 86.5% of the North America biological safety testing market in 2015. The dominant share attained by this region is a consequence of unprecedented adoption rate of unhealthy lifestyles, which has led to high prevalence and incidence of diseases, such as cancer and diabetes.

The aforementioned factor serves as a significant contributing factor enabling wide scale drug development and their subsequent commercialization by major biopharmaceutical companies present across this region. This is further believed to engender a greater need to ensure high safety standards for specialized and targeted therapies and avert probable shortcomings.

Moreover, healthcare organizations, such as the U.S. FDA, and U.S. Department of Health and Human Services in collaboration with Centers for Disease Control and Prevention and National Institutes of Health, consistently strive to improve the biological and microbiological safety testing standards for biomedical laboratories through the formulation and enforcement of stringent regulatory guidelines.

Reasons to subscribe to U.S. biological safety testing products and services market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of U.S. biological safety testing products and services market databook

  • Our clientele includes a mix of biological safety testing products and services market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the U.S. biological safety testing products and services market , including forecasts for subscribers. This country databook contains high-level insights into U.S. biological safety testing products and services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

U.S. biological safety testing products and services market size, by product, 2018-2030 (US$M)

U.S. Biological Safety Testing Products And Services Market Outlook Share, 2023 & 2030 (US$M)

U.S. biological safety testing products and services market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more